Target populations for first-in-human embryonic stem cell research in spinal cord injury.
about
Cellular treatments for spinal cord injury: the time is right for clinical trialsHuman pluripotent stem cells: Towards therapeutic development for the treatment of lifestyle diseasesThe Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and ChallengesConcise review: clinical programs of stem cell therapies for liver and pancreasCell therapy for spinal cord injury informed by electromagnetic waves.Ethical issues in stem cell research and therapyWhat is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.Hematopoietic, CNS and skeletal muscle stem cells as drug targets: opportunities, progress and challenges.Stem cell trials for cardiovascular medicine: ethical rationale.Modulating the stem cell niche for tissue regeneration.Wrongful termination: lessons from the Geron clinical trial.Current stem cell treatments for spinal cord injuryModern Brain Mapping - What Do We Map Nowadays?Miniaturized optogenetic neural implants: a review.Cell transplantation for spinal cord injury: a systematic reviewIcaritin enhances mESC self-renewal through upregulating core pluripotency transcription factors mediated by ERα.Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.Global update: USA.Concise review: human pluripotent stem cells in the treatment of spinal cord injury.A theoretical framework for early human studies: uncertainty, intervention ensembles, and boundaries.Concise review: cell therapy and tissue engineering for cardiovascular disease.Regenerative medicine interventions for orthopedic disorders: ethical issues in the translation into patients.The challenges of translating stem cells for spinal cord injury and related disorders: what are the barriers and opportunities?Bioprocessing of cryopreservation for large-scale banking of human pluripotent stem cells.Metabolic restructuring and cell fate conversion.A robust vitronectin-derived peptide for the scalable long-term expansion and neuronal differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs).Intramedullary Lesion Length on Postoperative Magnetic Resonance Imaging is a Strong Predictor of ASIA Impairment Scale Grade Conversion Following Decompressive Surgery in Cervical Spinal Cord Injury.Adapting Preclinical Benchmarks for First-in-Human Trials of Human Embryonic Stem Cell-Based Therapies.First-in-human HIV-remission studies: reducing and justifying risk.Tumor prevention facilitates delayed transplant of stem cell-derived motoneurons.Rapid generation of OPC-like cells from human pluripotent stem cells for treating spinal cord injuryNeural precursor cell transplantation enhances functional recovery and reduces astrogliosis in bilateral compressive/contusive cervical spinal cord injury.Large stem cell-derived cardiomyocyte grafts: cellular ventricular assist devices?Perceptions of Equipoise, Risk-Benefit Ratios, and "Otherwise Healthy Volunteers" in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative Inquiry.Print Me an Organ? Ethical and Regulatory Issues Emerging from 3D Bioprinting in Medicine.One Size Fits All?: Ethical Considerations for Examining Efficacy in First-in-Human Pluripotent Stem Cell Studies.Decision-making in stem cell trials for spinal cord injury: the role of networks and peers.Studying the lay of the land: views and experiences of professionals in the translational pluripotent stem cell field.Backward by Design: Building ELSI into a Stem Cell Science Curriculum.
P2860
Q24630772-D933EC43-6B80-42E2-9879-0944406BF429Q26765252-47A024AE-3DAC-492E-B315-8DD40A142FADQ26860309-C2B6745A-05E7-4711-8B74-808E9974F0DBQ30555472-45EDD17A-DD97-4177-A640-854F84F18E68Q33363830-D05DFEFD-23C7-468D-B11B-C1F5B6F8FB9FQ33900583-01217793-8B0F-406C-B915-C203DA9184AAQ34029285-1FA790DF-5641-4511-8712-C56F4913E93BQ34133412-55C098DD-9C00-49E7-80FC-EC678EC726F1Q34212796-F3288961-ED20-4D16-B3D7-BD280F82EB38Q34331206-00B5918C-3040-4779-B6D2-9BD7A514C5BCQ34432431-E77F9462-B91A-4AA6-B5F6-68B516CFA085Q34601960-BF9DF480-AA35-4F64-905B-2CB1C2737C95Q35726466-040EE87F-91BF-47DC-8DCA-E6A491013A67Q35746609-8403C4E2-44E5-4D4B-A68D-45F867AFD261Q35755959-A3FAD882-3216-445E-9640-1343A023EFE9Q36635432-7CF1F086-82DB-4571-9BE6-3B921BE5DA40Q37587765-52D869B1-B2A5-4654-AA65-8DA08BD54365Q37643268-9EC67D4A-1943-4377-B4FC-29CE7EAAE644Q37945692-8F673F25-E3DA-42D2-BABF-A3731028530BQ38021973-8246D5E0-7BAE-456E-958C-A478FA2A01C4Q38045514-9AF03D33-0C9B-48EE-9B05-DAA4598178F7Q38063849-D554EF87-68E4-4C34-8513-6F131F44E63DQ38069234-896FED0D-C15E-43EE-BD5A-6A3A801A839EQ38078024-1C260858-E2CE-470B-9C61-309B0C2BB2FFQ38091624-E5154EA7-8F54-4E91-B4E7-AA1F0CE8AA89Q38317505-33217D78-0DEA-4603-94F8-6448789F72B0Q38781123-D23A073F-E6DE-4A7D-8679-D370B34F9765Q38864592-3AC30D20-BB23-4FF8-ACBA-B02E840BD900Q38873789-D367F527-8384-42FA-99DE-C298A5008F69Q40688627-20A1C771-7A8E-4C26-97FE-4AA98E573BD8Q41117615-9D465BF1-8AC2-44D6-BCB8-44ACBA317642Q41480481-2FEB2530-8E5C-4B85-83F0-54198B064DD3Q41905129-AAFACB5F-C0F0-495E-AC4B-AE4A20C8467EQ41942689-17FEE659-10FF-43AF-A14B-FA5B833E0A62Q41990496-18E5DE91-7B9D-4BA0-8488-37E3F9DF23A8Q42696042-E18AB9EE-167A-4163-A7B8-047AB2E4E482Q46119000-4053CE05-CD5D-4CBC-AE75-E1DFF5A9EE22Q47361752-CAC84064-1A87-4764-8F57-8717B069A075Q47879705-5A0CA4D3-8287-40C0-A06C-06756E808248Q48039152-84FC9324-16D0-484C-B04C-D05549C34A34
P2860
Target populations for first-in-human embryonic stem cell research in spinal cord injury.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Target populations for first-in-human embryonic stem cell research in spinal cord injury.
@ast
Target populations for first-in-human embryonic stem cell research in spinal cord injury.
@en
Target populations for first-in-human embryonic stem cell research in spinal cord injury.
@nl
type
label
Target populations for first-in-human embryonic stem cell research in spinal cord injury.
@ast
Target populations for first-in-human embryonic stem cell research in spinal cord injury.
@en
Target populations for first-in-human embryonic stem cell research in spinal cord injury.
@nl
prefLabel
Target populations for first-in-human embryonic stem cell research in spinal cord injury.
@ast
Target populations for first-in-human embryonic stem cell research in spinal cord injury.
@en
Target populations for first-in-human embryonic stem cell research in spinal cord injury.
@nl
P50
P1433
P1476
Target populations for first-in-human embryonic stem cell research in spinal cord injury.
@en
P2093
Frédéric Bretzner
P304
P356
10.1016/J.STEM.2011.04.012
P407
P577
2011-05-01T00:00:00Z